ChemicalBook >
제품 카탈로그 >N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 구조식 이미지
카스 번호:
1260614-73-0
상품명:
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
동의어(영문):
Tofatinib Impurity 18;Tofacitinib IMpurity N;Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4S));N-Methyl-N-[(3S,4S)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3S,4S)-4-Methyl-3-piperidinyl]-
CBNumber:
CB02642727
분자식:
C13H19N5
포뮬러 무게:
245.32
MOL 파일:
1260614-73-0.mol
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 속성
녹는점
156-160°C
밀도
1?+-.0.06 g/cm3(Predicted)
저장 조건
2-8°C
용해도
메탄올(약간 용해됨), 물(약간 용해됨)
산도 계수 (pKa)
13.36±0.50(Predicted)
물리적 상태
고체
물리적 상태
단단한 모양
색상
회백색
안정성
흡습성
안전
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine C화학적 특성, 용도, 생산
용도
Tofacitinib impurity N is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 준비 용품 및 원자재
원자재
준비 용품
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 공급 업체
글로벌( 59)공급 업체
China 51
India 3
United States 5
Global 59
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 관련 검색:
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib related coMpound 2
Tofacitinib
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
Tofacitinib Impurity T
Ethyl S-4-chloro-3-hydroxybutyrate
2-amino-4-fluoro-5-nitrobenzoic acid
TF-A
(3R,4R)-N,4-dimethyl-piperidin-3-amine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
Tofacitinib Impurity 20
R-afatinib
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 19